articleThe LancetFeb 1, 2024BRONZE OA

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

University of Oxford · Jenner Institute · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

338
total citations
FWCI
170.10
Percentile
100%
References
9
Citations per year

Authors

119

Topics & keywords

Keywords
  • Malaria vaccine
  • Double blind
  • Malaria
  • Medicine
  • Phase (matter)
  • Virology
  • Immunology
  • Plasmodium falciparum
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding